Arrhythmia Research Technology, Inc. Reports 2015 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Medifast launches Trilivy, replacing its Optavia brand
Arrhythmia Research Technology (HRT) Posts Surprise Q3 Loss
November 12, 2015 8:12 AM ESTArrhythmia Research Technology (NYSE: HRT) reported Q3 EPS of ($0.10), $0.60 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $5.23 million versus the consensus estimate of $136.4 million.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
... More